Skip to main content

Paradigm Biocapital Advisors LP

Location
NEW YORK, NY
Portfolio Value
Mid $4,894,261,596
Diversification
Diversified
Filing Date
Global Rank
#676 / 8,603 ▲ 173 · as of Mar 2026
Top Industry
Biotechnology 100.0%
3Y Alpha vs SPY
+4.5%
Period ended 3 months ago
Filed May 15, 2026 · 55d
18 quarters · since Dec 2021

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+97.9%
SPY
+76.0%
Annualised alpha
+4.8%
Max drawdown
−47.9%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

35 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025
Top Position
13.5%
−1.3 pts
Top 5
48.3%
−3.8 pts
Top 10
67.6%
−8.7 pts
HHI
671
Jun 2023 → Mar 2026 · range 583 – 934
Diversified−112

Portfolio Trend

18 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Healthcare 100.0% $4,894,261,596

Last Quarter's Activity

Export CSV
Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased
13 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
7 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
10 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
3 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
35 positions · $4,894,261,596 total · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History